Specialized therapeutics
Oncology · Orphan drugs · Rare diseases
CANADA + USA → MIDDLE EAST
North American innovation.
Middle Eastern opportunity.
We bridge life-science innovation and commercial opportunity through the right partners, market pathways and strategy.
Discuss your portfolioCANADA + USA → MIDDLE EAST
Innovation has a new direction.
North Bridge Health connects North American life-science businesses with commercial opportunity across the GCC & MENA region.
CANADA + USA → SAUDI ARABIA · UAE · QATAR · OMAN · BAHRAIN · KUWAIT
We also support innovators from the United Kingdom, Europe and Australia.
WHO WE SERVE
For innovators ready for their next market.
- — Biotech innovators
- — Pharmaceutical manufacturers
- — Medical device companies
- — Diagnostics & digital health businesses
- — Rare-disease & orphan-drug developers
- — Oncology-focused companies
FIVE CONNECTED SERVICES
Commercial clarity. From portfolio to presence.
01
Portfolio matchmaking
Connect your portfolio with the right commercial partners.
Explore service ↗02Tender management
Bring structure and clarity to complex procurement processes.
Explore service ↗03Market access & regulatory navigation
Understand the route from regulatory requirements to market access.
Explore service ↗04Commercial expansion & team head-hunting
Build the commercial capabilities your next market requires.
Explore service ↗05Strategic advisory for specialized therapeutics
Develop a focused approach for complex, high-value portfolios.
Explore service ↗SPECIALIZED FOCUS
Complex science. Considered strategy.
Advanced medical technologies
Medical devices · Diagnostics · Digital health
REGIONAL OPPORTUNITY
A country-specific approach to expansion.
Saudi Arabia, UAE, Qatar, Oman, Bahrain and Kuwait each have distinct regulatory pathways, procurement channels and commercial priorities.
- Saudi Arabia
- United Arab Emirates
- Qatar
- Oman
- Bahrain
- Kuwait
WHY NORTH BRIDGE HEALTH
Focused expertise. Connected thinking.
01
Specialized portfolios
A focus on oncology, orphan drugs, rare diseases and advanced technologies.
02
Joined-up commercial planning
Partner selection, tender systems, pricing and reimbursement considered together.
03
Personal attention
A tailored consultancy approach combining global perspective with hands-on commercial support.
YOUR NEXT MARKET
Let’s build your commercial presence.
Bring your portfolio, questions and ambitions. Let’s explore the right next step.
Discuss your portfolio